Skip to content

HD-tDCS to Modulate Connectivity

Modulating Functional Brain Connectivity Using High Definition Transcranial Direct Current Stimulation (HD-tDCS)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05959551
Enrollment
100
Registered
2023-07-25
Start date
2023-07-01
Completion date
2026-08-31
Last updated
2026-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Electricity; Effects

Brief summary

The purpose of the proposed study is to broaden our understanding on the neural effects of High Definition Transcranial Direct Current Stimulation (HD-tDCS) so that its clinical effects can be further improved.

Detailed description

Normal healthy individuals will be recruited and undergo a standardized neuropsychological assessment (ANAM, MoCA, BDI-II, ToMS, and MAAS) and magnetic resonance imaging (MRI). During MRI, HD-tDCS will be applied. Four different stimulation targets will be investigated, and subjects will be randomly assigned for each target groups or sham group. After HD-tDCS/MRI session, subjects will be re-assessed with standardized neuropsychological tests.

Interventions

HD-tDCS will be provided for 20 minutes for each stimulation with peak intensity of 2mA.

Sponsors

University of Manitoba
Lead SponsorOTHER
Natural Sciences and Engineering Research Council, Canada
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Masking description

Randomization will happen after baseline assessment. After-intervention assessment will only consist of self-report and computerized assessment. Participants will not aware of the treatment group that they were assigned to.

Intervention model description

4 active treatment groups + 1 inactive treatment group

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

\- All other than excluded.

Exclusion criteria

* History or susceptibility to any neurological or psychiatric diseases, particularly seizures * abnormal MRI * metal implants or a cardiac pacemaker * pregnant or breastfeeding women

Design outcomes

Primary

MeasureTime frameDescription
change of functional connectivity0-11 minutes after the stimulation contrasting baseline (before stimulation)Changes in seed-based connectivity originating from the targeted brain regions immediately after the brain stimulation

Secondary

MeasureTime frameDescription
change of cerebral blood flow12-16 minutes after the stimulation contrasting baseline (before stimulation)Changes in Cerebral Blood Flow (estimated using pseudo continuous arterial spin labeling )
Toronto Mindfulness Scale (curiosity)Baseline, then within 1-2 hours from stimulationmindfulness scale for curiosity. min: 0, max: 30. Higher score means higher curiosity-mindfulness.
Toronto Mindfulness Scale (decentering)Baseline, then within 1-2 hours from stimulationmindfulness scale for decentering. min: 0, max: 35. Higher score means higher decentering-mindfulness.

Countries

Canada

Contacts

CONTACTJi Hyun Ko, PhD
ji.ko@umanitoba.ca2042930724

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 2, 2026